465.00GBP+1.09%Mkt Cap: 92.35M $P/E: —1d ago
4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally. It offers hpDNA, a double s…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap92.35M $
Enterprise Value90.98M $
Revenue (TTM)2.17M $
Gross Profit1.25M $
Net Income (TTM)-21.68M $
Revenue/Share0.1398 USD
Last Price465.00 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees140
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.75
PEG—
EV/EBITDA-4.50
EV/Revenue41.90
P/S42.53
P/B7.14
EPS (TTM)-1.09
EPS (Forward)-0.60
52W Range
0.000047% of range1000.00
52W High1000.00 GBP
52W Low0.0000 GBP
Profitability
Gross Margin57.53%
Oper. Margin-1604.24%
EBITDA Margin0.00%
Profit Margin-998.52%
ROE-167.19%
ROA-57.21%
Growth
Revenue Growth-14.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.99M $
CapEx (TTM)2.10M $
FCF Margin-717.92%
FCF Yield-16.88%
Net Debt-1.70M $
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity1.65
Current Ratio7.31
Quick Ratio6.91
Book Value/Sh0.6510 GBP
Cash/Share1.161 GBP
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBP
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1600.00 GBP
Upside (mean)+244.1%
Target Range1400.00 GBP – 1800.00 GBP
GBP1400.00+244.1% to meanGBP1800.00
# Analysts2
Ownership
Shares Out.15.48M
Float5.74M
Insiders60.56%
Institutions14.17%
Technical
SMA 50523.78 (-11.2%)
SMA 200554.75 (-16.2%)
Beta0.87
S&P 52W Chg18.16%
Avg Vol (30d)306
Avg Vol (10d)863
Technical Indicators
RSI (14)26.3
MACD-8.2166
MACD Signal-1.0936
MACD Hist.-7.1230
BB Upper564.51 GBP
BB Middle519.60 GBP
BB Lower474.69 GBP
BB Width17.29%
ATR (14)31.44 GBP
Vol Ratio (20d)4.63x